How are relapse or flare episodes managed in chronic enteropathy?

• A. Ignore relapse and continue current therapy.
• B. Switch to an entirely new therapy with no assessment.
• C. Re-escalate therapy to the previous effective regimen (diet, antibiotics, or immunosuppressants) and reassess.
• D. Stop therapy and observe without intervention.

Answer: (C)

Relapse in chronic enteropathy means the disease has become active again after a period of control, so the first and most practical move is to return to the regimen that previously brought improvement and reassess how it’s working. Re-escalating to the prior effective plan—whether it was a specific diet, antibiotics, or an immunosuppressant—and then monitoring the patient allows you to quickly restore control while you check for what changed: adherence, dosing adequacy, or a new trigger or complication.

In practice, if the diet was the driver of control, reintroduce and reinforce that dietary plan and watch for a response. If antibiotics were part of the control strategy, restart them at the appropriate course and duration, then reassess. If immunosuppressants were used, resume the effective dose to regain control and then taper carefully based on response. The reassessment should include clinical signs, weight, stool quality, appetite, and, as needed, targeted diagnostics and evaluation of adherence, side effects, and potential triggers.

Ignoring relapse, switching to a completely new therapy without assessment, or stopping therapy does not re-establish control and risks ongoing inflammation and damage. Re-escalation to a known effective regimen with careful reassessment is the most logical, effective approach.